eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
3/2021
vol. 46
 
Share:
Share:
more
 
 
abstract:
Case report

Achromobacter denitrificans pneumonia in a kidney transplant recipient – dose-dependent decrease of phagocytic activity as a potential mechanism for everolimus pulmonary toxicity

Justyna Eliza Gołębiewska
1
,
Ewa Bryl
2
,
Agnieszka Daca
2
,
Andrzej Chamienia
1
,
Dominik Świętoń
3
,
Alicja Dębska-Ślizień
1

1.
Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Poland
2.
Department of Pathology and Experimental Rheumatology, Medical University of Gdańsk, Poland
3.
Department of Radiology, Medical University of Gdańsk, Poland
Cent Eur J Immunol 2021; 46 (3): 405-417
Online publish date: 2021/09/28
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Mammalian target of rapamycin (mTOR) inhibitors inclusive regimens are associated with increased risk of pulmonary toxicity, but the underlying mechanism has not been elucidated so far.

We present the case of a 68-year-old man, after deceased-donor kidney transplantation (KTx), maintained on de novo everolimus (EVR) based immunosuppression, who developed Achromobacter denitrificans pneumonia 3 months after KTx. There was clinical improvement with antibiotic treatment, but without a radiological resolution. An additional reduction of the EVR dose resulted only in partial resolution of radiological abnormalities. We performed a functional analysis of peripheral blood neutrophils and monocytes. The ability of phagocytosis and oxidative burst generation against A. denitrificans and Escherichia coli was significantly decreased on EVR treatment as compared to the control healthy person, and significantly improved after 3 weeks of EVR absence. Additionally, these processes were significantly affected by increasing doses of EVR in vitro in the control healthy donor in a dose-dependent manner. EVR discontinuation, with no additional antibiotic treatment, resulted in complete recovery and resolution of pulmonary infiltrates.

Our findings suggest that dose-dependent impairment of neutrophil/monocyte phagocytic activity and oxidative burst generation might be a potential mechanism for EVR pulmonary toxicity.
keywords:

kidney transplantation, Achromobacter denitrificans, mTOR inhibitors, everolimus, phagocytosis, oxidative burst generation

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.